StonvexLoading…
StonvexStonvexStonvexCore line items from CPT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $394.83M | $2.14M | $12.97M | $7.68M | $5.12M |
Operating Income | Not available | Not available | Not available | Not available | Not available |
Net Income | Not available | $42.45M | $384.46M | $228.43M | $119.49M |
EPS (Diluted) | $0.24 | $0.40 | $3.54 | $2.10 | $1.10 |
Total Assets | Not available | $9.06B | $9.04B | $9.06B | $9.12B |
Total Liabilities | Not available | $4.95B | $4.60B | $4.44B | $4.46B |
Cash & Equivalents | Not available | $40.68M | $25.20M | $25.93M | $33.09M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 101.90M | 104.30M | 106.40M | 106.90M |